Quarterly Call Option Transactions in Halozyme Therapeutics, Inc. (HALO)
This table provides information about the institutional ownership of Halozyme Therapeutics, Inc. (HALO) during . The information is specifically focused on institutions that hold call options of HALOZYME THERAPEUTICS, INC..
Calls Purchased
Calls Sold
Quarter | Buy | Sell | Net Activity | |||||
---|---|---|---|---|---|---|---|---|
New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
Q3 2021 | 48,400 | 61,193 | 109,593 | 34,100 | 40,000 | 74,100 | 35,493 | |
Q4 2021 | 38,600 | 147,000 | 185,600 | 128,400 | 53,800 | 182,200 | 3,400 | |
Q1 2022 | 58,600 | 62,000 | 120,600 | 68,600 | 0 | 68,600 | 52,000 | |
Q2 2022 | 500 | 0 | 500 | 84,300 | 95,600 | 179,900 | -179,400 | |
Q3 2022 | 68,300 | 400 | 68,700 | 30,900 | 0 | 30,900 | 37,800 | |
Q4 2022 | 33,500 | 232,900 | 266,400 | 200 | 0 | 200 | 266,200 | |
Q1 2023 | 3,400 | 7,700 | 11,100 | 35,300 | 0 | 35,300 | -24,200 | |
Q2 2023 | 6,000 | 211,900 | 217,900 | 38,100 | 0 | 38,100 | 179,800 | |
Q3 2023 | 10,900 | 22,800 | 33,700 | 64,800 | 0 | 64,800 | -31,100 | |
Q4 2023 | 25,400 | 42,800 | 68,200 | 82,600 | 0 | 82,600 | -14,400 | |
Q1 2024 | 7,800 | 78,400 | 86,200 | 29,800 | 0 | 29,800 | 56,400 | |
Q2 2024 | 30,600 | 0 | 30,600 | 26,900 | 0 | 26,900 | 3,700 | |
Q3 2024 | 72,200 | 121,800 | 194,000 | — | 194,000 |